Bottom line
BIPSX vs XBI: the short answer
BIPSX (Biotechnology Ultrasector Profund) and XBI (State Street(R) SPDR(R) S&P(R) Biotech ETF) are both mutual funds.
XBI is cheaper at 0.35% vs 2.52% — a difference of $217 a year per $10,000 invested.
Over five years, BIPSX returned +5.0% a year vs −2.7% for XBI (reporting dates differ).
Updated Nov 19, 2026
BIPSX vs XBI side by side
| BIPSX | XBI | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | ProShares | SPDR (State Street) |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 2.52% | 0.35% |
| Annual cost per $10k | $252 | $35 |
| 10-yr cost on $10k (prospectus) | $2,856 | $443 |
| Max front load | — | None |
| 12b-1 fee | 1% | 0% |
| 1-yr return | −6.2% | +35.8% |
| 5-yr return (annualized) | +5.0% | −2.7% |
| 10-yr return (annualized) | +3.4% | +5.8% |
| Best quarter | — | +44.4% |
| Worst quarter | — | −26.2% |
| Net assets (fund) | $118.7M | $10.7B |
| Number of holdings | 159 | 161 |
| Portfolio turnover | 52% | 71% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
12 of BIPSX's top 25 holdings also appear in XBI's top 25.
| Holding | BIPSX | XBI |
|---|---|---|
| Apogee Therapeutics Inc | 1.29% | 1.49% |
| Oruka Therapeutics Inc | 1.20% | 1.38% |
| Dianthus Therapeutics Inc | 1.12% | 1.18% |
| Erasca Inc | 1.08% | 1.27% |
| Twist Bioscience Corp | 1.08% | 1.41% |
| Kymera Therapeutics Inc | 1.05% | 1.36% |
| Revolution Medicines Inc | 1.04% | 1.20% |
| Cg Oncology Inc | 1.03% | 1.20% |
| Praxis Precision Medicines Inc | 1.02% | 1.29% |
| Cogent Biosciences Inc | 0.99% | 1.14% |
| Natera Inc | 0.99% | 1.16% |
| Travere Therapeutics Inc | 0.95% | 1.13% |
Source: SEC Form N-PORT
BIPSX top 10
- N/a — 6.70%
- N/a — 5.15%
- N/a — 4.12%
- N/a — 4.12%
- N/a — 3.16%
- Agpxx — 2.40%
- Apogee Therapeutics Inc — 1.29%
- N/a — 1.24%
- Oruka Therapeutics Inc — 1.20%
- Dianthus Therapeutics Inc — 1.12%
XBI top 10
- State Street Global Advisors — 5.87%
- Apogee Therapeutics Inc — 1.49%
- Moderna Inc — 1.41%
- Twist Bioscience Corp — 1.41%
- Oruka Therapeutics Inc — 1.38%
- Kymera Therapeutics Inc — 1.36%
- Viking Therapeutics Inc — 1.30%
- Praxis Precision Medicines Inc — 1.29%
- Erasca Inc — 1.27%
- Revolution Medicines Inc — 1.20%
FAQ
What is the difference between BIPSX and XBI?
BIPSX (Biotechnology Ultrasector Profund) and XBI (State Street(R) SPDR(R) S&P(R) Biotech ETF) are both mutual funds. XBI is cheaper at 0.35% vs 2.52% — a difference of $217 a year per $10,000 invested.
Which is cheaper, BIPSX or XBI?
XBI has the lower expense ratio (0.35%).
Should I own both BIPSX and XBI?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.